Peter Ruminski

2.8k total citations · 2 hit papers
42 papers, 2.0k citations indexed

About

Peter Ruminski is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Peter Ruminski has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Hematology. Recurrent topics in Peter Ruminski's work include Synthesis of heterocyclic compounds (7 papers), Cell Adhesion Molecules Research (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Peter Ruminski is often cited by papers focused on Synthesis of heterocyclic compounds (7 papers), Cell Adhesion Molecules Research (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Peter Ruminski collaborates with scholars based in United States, United Kingdom and South Africa. Peter Ruminski's co-authors include David W. Griggs, Steven L. Settle, Michael J. Prinsen, Adam Lacy‐Hulbert, Marilyn M. Giacomini, Yoshio Katamura, Antonella Pellicoro, Jacquelyn J. Maher, Joseph H. McCarty and Juan Duque Rodríguez and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Peter Ruminski

39 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs

2013 648 citations Neil C. Henderson, Thomas D. Arnold et al. profile →
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo

2012 519 citations Peter Ruminski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Ruminski United States	16	612	595	352	298	230	42	2.0k
Michael D. Oberst Germany	29	296 0.5×	1.1k 1.8×	473 1.3×	283 0.9×	259 1.1×	77	2.7k
Lora W. Barsky United States	27	531 0.9×	780 1.3×	352 1.0×	141 0.5×	112 0.5×	39	2.1k
Robbert van der Voort Netherlands	28	1.4k 2.2×	658 1.1×	1.1k 3.0×	115 0.4×	285 1.2×	43	2.4k
Ido D. Weiss United States	30	1.0k 1.6×	568 1.0×	977 2.8×	159 0.5×	160 0.7×	48	2.3k
A Martínez-Hernández United States	19	200 0.3×	616 1.0×	291 0.8×	764 2.6×	392 1.7×	31	2.2k
Lars H. Engelholm Denmark	31	571 0.9×	1.3k 2.2×	1.1k 3.1×	730 2.4×	133 0.6×	79	3.4k
Haifeng C. Xu Germany	24	1.2k 2.0×	543 0.9×	713 2.0×	84 0.3×	258 1.1×	60	2.4k
Guimei Zhang China	24	1.5k 2.4×	948 1.6×	754 2.1×	154 0.5×	82 0.4×	60	2.7k
Risto Ala‐aho Finland	23	298 0.5×	1.3k 2.1×	942 2.7×	264 0.9×	53 0.2×	27	2.6k
Tatiana I. Novobrantseva United States	24	1.4k 2.2×	1.5k 2.5×	422 1.2×	87 0.3×	264 1.1×	42	3.3k

Countries citing papers authored by Peter Ruminski

Since Specialization

Citations

This map shows the geographic impact of Peter Ruminski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruminski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruminski more than expected).

Fields of papers citing papers by Peter Ruminski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ruminski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruminski. The network helps show where Peter Ruminski may publish in the future.

Co-authorship network of co-authors of Peter Ruminski

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ruminski. A scholar is included among the top collaborators of Peter Ruminski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ruminski. Peter Ruminski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Sena, Peter Ruminski, Megh Singh, et al.. (2024). Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model. Molecules. 29(8). 1801–1801. 2 indexed citations

Li, Chang, Peter Ruminski, Michael P. Rettig, et al.. (2024). A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood Advances. 8(15). 4089–4101. 7 indexed citations

Cancilla, Daniel, Michael P. Rettig, Darja Karpova, et al.. (2024). Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization. Blood Advances. 8(6). 1379–1383. 7 indexed citations

Ruminski, Peter, Michael P. Rettig, & John F. DiPersio. (2024). Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells. Biomolecules. 14(8). 1003–1003. 3 indexed citations

Ruminski, Peter, Michael P. Rettig, Stephanie Christ, et al.. (2023). Novel Small Molecule VLA-4 Inhibitors Optimized for Extended Hematopoietic and Progenitor Cell Mobilization. Blood. 142(Supplement 1). 6778–6778. 1 indexed citations

Borcherding, Dana C., Yang Lyu, Carina Dehner, et al.. (2023). MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 29(8). 1592–1604. 14 indexed citations

Ruminski, Peter, Michael P. Rettig, Stephanie Christ, et al.. (2022). Optimized Small Molecule VLA-4 Inhibitors for Hematopoietic Stem and Progenitor Cell Mobilization. Blood. 140(Supplement 1). 4477–4478. 1 indexed citations

Noskovičová, Nina, Ronen Schuster, Sander van Putten, et al.. (2021). Suppression of the fibrotic encapsulation of silicone implants by inhibiting the mechanical activation of pro-fibrotic TGF-β. Nature Biomedical Engineering. 5(12). 1437–1456. 111 indexed citations

Persaud, Stephen P., Julie Ritchey, Sena Kim, et al.. (2021). Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation. Journal of Clinical Investigation. 131(24). 15 indexed citations

10.

Schober, Joseph, et al.. (2018). Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding. Frontiers in Bioengineering and Biotechnology. 6. 129–129. 27 indexed citations

11.

Ulmasov, Barbara, Brent A. Neuschwander‐Tetri, Jinping Lai, et al.. (2016). Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 2(4). 499–518. 25 indexed citations

12.

Singh, Kawaljit, Krupa Naran, Daniel F. Hoft, et al.. (2016). Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis. ACS Infectious Diseases. 2(10). 714–725. 16 indexed citations

13.

Griggs, David W., Michael J. Prinsen, Mary Ann Campbell, et al.. (2016). Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea. Journal of Pharmacology and Experimental Therapeutics. 357(2). 423–431. 10 indexed citations

14.

Henderson, Neil C., Thomas D. Arnold, Yoshio Katamura, et al.. (2013). OC-002 Selective Alpha V Integrin Deletion Identifies a Core, Targetable Molecular Pathway that Regulates Fibrosis Across Solid Organs. Gut. 62(Suppl 1). A1.2–A1. 2 indexed citations

15.

Settle, Steven L., Olga V. Nemirovskiy, Tom Vidmar, et al.. (2010). Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes. Arthritis & Rheumatism. 62(10). 3006–3015. 62 indexed citations

16.

Nagarajan, Srinivasan, Balekudru Devadas, James W. Malecha, et al.. (2007). R-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors. Bioorganic & Medicinal Chemistry. 15(11). 3783–3800. 14 indexed citations

17.

Engleman, V. Wayne, G. Allen Nickols, F. Patrick Ross, et al.. (1997). A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.. Journal of Clinical Investigation. 99(9). 2284–2292. 228 indexed citations

18.

Ruminski, Peter, et al.. (1987). SYNTHESIS OF ALKYL N-CYANO-N-SUBSTITUTED THIOLCARBAMATES. Phosphorous and Sulfur and the Related Elements. 29(1). 1–10. 1 indexed citations

19.

D'Amico, John J., et al.. (1985). Synthesis of 2‐thioxo‐3‐benzothiazolineacetonitrile and related products. Journal of Heterocyclic Chemistry. 22(6). 1479–1482. 14 indexed citations

20.

D'Amico, John J., et al.. (1985). HETEROCYCLIC AND RELATED COMPOUNDS DERIVED FROM DIPOTASSIUM 1,1-DIMERCAPTO-2,2-DICYANOETHYLENE AND SODIUM 2-MERCAPTOPYRIDINE N-OXIDE. Phosphorous and Sulfur and the Related Elements. 21(3). 307–314. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact